Subscribe
Magazine
Videos
Advertise
About Us
Smart Water Summit
Wastewater Summit
Drinking Water
Smart Water
Asset Management
Water Utility Management
Water Reuse
Global Thought Leaders
Podcast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
WaterWorld Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NBIX
Recent news which mentions NBIX
< Previous
1
2
3
4
Next >
Neurocrine Biosciences (NBIX) Q2 2022 Earnings Call Transcript
August 05, 2022
Tickers
NBIX
Tags
Market News
NBIX
Recent Press Releases
From
Motley Fool
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Tickers
ABUS
ACAD
ADAP
AGIO
Tags
AMGN
PDSB
IBB
From
Benzinga
Needham Previews Neurocrine's Upcoming Mid-Stage Data from Essential Tremor Study
July 11, 2022
Tickers
JAZZ
NBIX
PRAX
Tags
Analyst Color
JAZZ
NBIX
From
Benzinga
Neurocrine Biosciences Earnings Perspective: Return On Capital Employed
May 19, 2022
Tickers
NBIX
Tags
Benzinga
Earnings
BZI/ROCE
From
Benzinga
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
May 13, 2022
Tickers
BBIO
BFRI
BMY
BTTX
Tags
BMY
Health Care
PRPH
From
Benzinga
Neurocrine Biosciences (NBIX) Q1 2022 Earnings Call Transcript
May 05, 2022
Tickers
NBIX
Tags
Market News
NBIX
Recent Press Releases
From
Motley Fool
Neurocrine Biosciences: Q1 Earnings Insights
May 04, 2022
Tickers
NBIX
Tags
Earnings
Market News
NBIX
From
Benzinga
Neurocrine Biosciences Q1 2022 Earnings Conference Call On May 4, 2022 At 08:00 AM ET
April 25, 2022
Tickers
NBIX
Tags
Benzinga
BZI/CONF
News
From
Benzinga
What 8 Analyst Ratings Have To Say About Neurocrine Biosciences
April 04, 2022
Tickers
NBIX
Tags
BZI/AAR
Benzinga
Analyst Ratings
From
Benzinga
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
March 29, 2022
Tickers
AKBA
ALDX
AMPE
ATRS
Tags
IMAB
OPGN
IBB
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
March 03, 2022
Tickers
ALGT
AORT
AVTX
BALY
Tags
Downgrades
QRVO
VALE
From
Benzinga
Where Neurocrine Biosciences Stands With Analysts
February 25, 2022
Tickers
NBIX
Tags
BZI/AAR
Benzinga
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2022
February 25, 2022
Tickers
AAOI
AMED
AMPG
AXON
Tags
CELZ
Initiation
HMPT
From
Benzinga
Looking Into Neurocrine Biosciences's Return On Capital Employed
February 14, 2022
Tickers
NBIX
Tags
Benzinga
NBIX
Earnings
From
Benzinga
Neurocrine Biosciences (NBIX) Q4 2021 Earnings Call Transcript
February 11, 2022
Tickers
NBIX
Tags
NBIX
Market News
Recent Press Releases
From
Motley Fool
Why Neurocrine Biosciences Are Trading Higher Today?
February 11, 2022
Tickers
NBIX
Tags
Health Care
Biotech
Biotechnology
From
Benzinga
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
February 11, 2022
Tickers
BIO
DXCM
FRLN
GRAY
Tags
IBB
Guidance
FRLN
From
Benzinga
Recap: Neurocrine Biosciences Q4 Earnings
February 11, 2022
Tickers
NBIX
Tags
Benzinga
Earnings
Market News
From
Benzinga
Earnings Scheduled For February 11, 2022
February 11, 2022
Tickers
AB
APO
ARES
AXL
Tags
Markets
BRKR
COOP
From
Benzinga
A Preview Of Neurocrine Biosciences's Earnings
February 10, 2022
Tickers
NBIX
Tags
NBIX
BZI/EP
Earnings
From
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Tickers
ABBV
ACLX
ALNY
AMGN
Tags
QGEN
LH
Benzinga
From
Benzinga
Analyst Ratings For Neurocrine Biosciences
February 01, 2022
Tickers
NBIX
Tags
Benzinga
BZI/AAR
NBIX
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
January 18, 2022
Tickers
ABNB
ADTH
AGI
AHI
Tags
VTEX
PRDS
SCVL
From
Benzinga
10 Biggest Price Target Changes For Tuesday
January 18, 2022
Tickers
AVB
BIIB
EAT
JBHT
Tags
JBHT
Health Care
BIIB
From
Benzinga
Xenon Receives $15M Regulatory Milestone Under Epilepsy Pact With Neurocrine
January 12, 2022
Tickers
NBIX
XENE
Tags
Movers
NBIX
Briefs
From
Benzinga
Analyst Ratings For Neurocrine Biosciences
January 07, 2022
Tickers
NBIX
Tags
Analyst Ratings
Market News
NBIX
From
Benzinga
The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs
January 07, 2022
Tickers
AMLX
CINC
FDMT
GKOS
Tags
IBB
AMLX
Guidance
From
Benzinga
Expert Ratings For Neurocrine Biosciences
December 08, 2021
Tickers
NBIX
Tags
Market News
Analyst Ratings
NBIX
From
Benzinga
The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom
December 08, 2021
Tickers
ACET
AMAM
AMRX
BIIB
Tags
NBIX
TXMD
General
From
Benzinga
Neurocrine's Ingrezza Meets Primary Goal In Phase 3 Study In Patients With Involuntary Muscle Movement
December 08, 2021
Tickers
NBIX
Tags
Briefs
News
NBIX
From
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.